[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577845":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":37,"responsibleParty":69,"collaborators":31,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":31,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":31,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":31,"overallStatus":39,"whyStopped":31,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment Group","EXPERIMENTAL","Patients with Gastroparesis",[13],"Drug: Growth Hormone",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Growth Hormone","Subjects will receive somapacitan-beco (Sogroya®) administered as a subcutaneous injection once weekly for 12 weeks.\n\nAll participants will receive a fixed dose of 1.5 mg weekly, regardless of sex.",[9],[21],"Sogroya (Somapacitan-beco injections)",[23],{"name":24,"affiliation":5,"role":25},"Tisha Lunsford","PRINCIPAL_INVESTIGATOR",[27,33],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"Guillermo GI Program Coordinator, Research","CONTACT","480-301-4679",null,"barahona.guillermo@mayo.edu",{"name":34,"role":29,"phone":31,"phoneExt":35,"email":36},"Tisha Lunsford, MD","480-301-6990","lunsford.tisha@mayo.edu",[38,54],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Phoenix","Arizona","85054","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-112.07404,33.44838,{"lat":49,"lon":48},[52],{"name":53,"role":29,"phone":30,"phoneExt":31,"email":31},"Guillermo Barahona Hernandez, Sr. Progam Coordiantor",{"facility":55,"status":39,"city":56,"state":41,"zip":57,"country":43,"countryCode":44,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Mayo Clinic in Arizona","Scottsdale","85259",{"type":46,"coordinates":59},[60,61],-111.89903,33.50921,{"lat":61,"lon":60},[64,66,67],{"name":65,"role":29,"phone":31,"phoneExt":31,"email":32},"Guillermo Barahona Hernandez, Program Coordinator, Research, 480-301-4679",{"name":34,"role":29,"phone":35,"phoneExt":31,"email":36},{"name":68,"role":25,"phone":31,"phoneExt":31,"email":31},"Tisha Najet Lunsford",{"type":25,"investigatorFullName":70,"investigatorTitle":71,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Tisha N. Lunsford","GI and Hepatology Consultant","100577845","early-phase-1-growth-hormone-for-the-treatment-of-gastroparesis-100577845",false,"NCT06803589","Growth Hormone for the Treatment of Gastroparesis","Low-dose Growth Hormone for the Treatment of Gastroparesis","Inclusion Criteria:\n\n* Symptoms \\> 6 months that have not responded satisfactorily to standard treatment.\n* For gastroparesis: Gastroparesis Cardinal Symptom Index (GCSI) score of \\>21\n\nExclusion Criteria:\n\n* Known history of GH deficiency, hypothalamic or pituitary disease\n* Diabetes\n* Prior use of GH therapy\n* Age-adjusted low serum IGF1\n* Women on oral estrogen therapy6\n* Pregnancy or nursing\n* History of malignant solid tumors\n* Obesity (BMI \\> 30)History of coronary and thromboembolic diseases.\n* History of sarcoidosis\n* History of pituitary surgery\n* History of thyroid nodules.\n* Any other condition, which in the opinion of the investigator would impede compliance or hinder completion of the study.\n* Failure to give informed consent.","ALL","18 Years","65 Years",{"count":83,"type":84},10,"ESTIMATED","INTERVENTIONAL",[87],"EARLY_PHASE1","The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.",[90],"Gastroparesis","2026-04-13",{"date":93,"type":94},"2026-04-16","ACTUAL",{"date":96,"type":94},"2024-10-22",{"date":98,"type":84},"2027-12",{"name":5,"class":6},2]